Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique

• Register: ClinicalTrials.gov
• Last refreshed on: 22 May 2023
• Main ID: NCT02371265
• Date of registration: 18/02/2015
• Prospective Registration: No
• Primary sponsor: University of Washington
• Public title: Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
• Scientific title: Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
• Date of first enrolment: April 2012
• Target sample size: 761
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02371265
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Mozambique

Contacts

• Name: Rachel Chapman, PhD
• Affiliation: University of Washington

Key inclusion & exclusion criteria

Inclusion Criteria:

- Pregnant women who test HIV-positive in antenatal care services at target health
facilities

Exclusion Criteria:

- Pregnant women who arrived at health facilities who already have tested positive

- HIV-positive pregnant women who cannot start ART



Age minimum: 14 Years
Age maximum: 50 Years
Gender: Female

Health Condition(s) or Problem(s) studied

HIV

Intervention(s)

Other: Adherence and retention package

Primary Outcome(s)

Retention at 30 days [Time Frame: 45 days]

Adherence at 90 days [Time Frame: 90 days]

Secondary ID(s)

1R01HD074557-01

42773

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Beira Operations Research Center, Mozambique Ministry of Health

Health Alliance International